Adicet Bio Inc (ACET)

Nov 20, 2024

Adicet Bio Reports Q3 2024 Results and Clinical Progress - TipRanks

Nov 20, 2024

Nov 20, 2024

Adicet Bio (NASDAQ:ACET) Earns “Neutral” Rating from HC Wainwright - Defense World

Nov 20, 2024

Nov 19, 2024

First Patient Dosed in Trial for Adicet's T-Cell Therapy ADI-100 in Autoimmune Disease - CGTLive™

Nov 19, 2024

Nov 19, 2024

Adicet Bio To Present At Jefferies London Healthcare Conference; Webcast At 7:30 AM ET - Nasdaq

Nov 19, 2024

Nov 19, 2024

Adicet Bio begins trial for innovative cancer therapy By Investing.com - Investing.com Canada

Nov 19, 2024

Nov 18, 2024

Adicet Bio Advances Cancer and Autoimmune Trials - TipRanks

Nov 18, 2024

Nov 18, 2024

Adicet Opens Enrollment for ADI-270 Phase 1 Clinical Trial in Metastatic/Advanced Clear Cell Renal Cell Carcinoma - Business Wire

Nov 18, 2024

Nov 18, 2024

Adicet Bio (NASDAQ:ACET) Receives Neutral Rating from HC Wainwright - MarketBeat

Nov 18, 2024

Nov 18, 2024

Adicet Bio begins lupus nephritis trial, eyes other diseases By Investing.com - Investing.com UK

Nov 18, 2024

Nov 18, 2024

Adicet Bio Launches Phase 1 Trial for Lupus Drug with FDA Fast Track Status | ACET Stock News - StockTitan

Nov 18, 2024

Nov 18, 2024

Is Adicet Bio (NASDAQ:ACET) In A Good Position To Deliver On Growth Plans? - Yahoo Finance

Nov 18, 2024

Nov 16, 2024

Adicet Bio's ADI-001 Shows Breakthrough CAR T Cell Results in Autoimmune Treatment Study | ACET Stock News - StockTitan

Nov 16, 2024

Nov 16, 2024

Adicet Bio amends loan terms with PacWest Bank - Investing.com India

Nov 16, 2024

Nov 15, 2024

RA Capital Management, L.P. Expands Stake in Adicet Bio Inc - GuruFocus.com

Nov 15, 2024

Nov 12, 2024

Adicet Bio To Present At Guggenheim Securities Healthcare Innovation Conference; Webcast At 3:00 PM - Nasdaq

Nov 12, 2024

Nov 11, 2024

FY2024 EPS Estimates for Adicet Bio Lowered by HC Wainwright - MarketBeat

Nov 11, 2024

Nov 11, 2024

HC Wainwright Decreases Earnings Estimates for Adicet Bio - Defense World

Nov 11, 2024

Nov 09, 2024

Wedbush Reiterates “Outperform” Rating for Adicet Bio (NASDAQ:ACET) - Defense World

Nov 09, 2024

Nov 07, 2024

Adicet Bio (NASDAQ:ACET) Announces Earnings Results, Hits Estimates - MarketBeat

Nov 07, 2024

Nov 06, 2024

Adicet Reports Third Quarter 2024 Financial Results and Provides Business Updates - StockTitan

Nov 06, 2024

Nov 05, 2024

Adicet Bio to Present at the American College of Rheumatology (ACR) Convergence 2024 - Business Wire

Nov 05, 2024

Nov 05, 2024

Adicet Bio to Present Breakthrough CAR T Cell Therapy at ACR Convergence 2024 | ACET Stock News - StockTitan

Nov 05, 2024

Nov 01, 2024

Adicet Bio to Participate in Upcoming Investor Conferences - Business Wire

Nov 01, 2024

Oct 31, 2024

Adicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - StockTitan

Oct 31, 2024

Oct 18, 2024

HC Wainwright Reiterates Neutral Rating for Adicet Bio (NASDAQ:ACET) - Defense World

Oct 18, 2024

Oct 17, 2024

Adicet Bio shares maintain Neutral rating after FDA IND amendment - Investing.com India

Oct 17, 2024

Oct 17, 2024

Adicet Bio shares maintain Neutral rating after FDA IND amendment By Investing.com - Investing.com Australia

Oct 17, 2024

Oct 17, 2024

Adicet Bio Advances FDA-Approved Autoimmune Therapy Trials - Yahoo Finance

Oct 17, 2024

Oct 16, 2024

FDA greenlights Adicet Bio's trial expansion for autoimmune diseases - Investing.com

Oct 16, 2024

Oct 16, 2024

Adicet Bio Announces FDA Clearance of IND Amendment to Evaluate ADI-001 in Idiopathic Inflammatory Myopathy and Stiff Person Syndrome - StockTitan

Oct 16, 2024

Oct 15, 2024

Adicet Bio, Inc. (NASDAQ:ACET) Short Interest Down 11.0% in September - MarketBeat

Oct 15, 2024

Oct 13, 2024

Adicet Bio, Inc. (NASDAQ:ACET) Shares Bought by Cubist Systematic Strategies LLC - MarketBeat

Oct 13, 2024

Oct 08, 2024

Adicet Bio (NASDAQ:ACET) Raised to "Hold" at StockNews.com - MarketBeat

Oct 08, 2024

Oct 08, 2024

Millennium Management LLC Adjusts Stake in Adicet Bio Inc - GuruFocus.com

Oct 08, 2024

Oct 04, 2024

Renaissance Technologies LLC Has $1.83 Million Stock Holdings in Adicet Bio, Inc. (NASDAQ:ACET) - MarketBeat

Oct 04, 2024

Oct 03, 2024

Adicet Bio Inc’s Shares Reel: 36.70% Quarterly Revenue Decline Amid 122.78M Market Cap - The InvestChronicle

Oct 03, 2024

Oct 03, 2024

Did Adicet Bio Inc (ACET) perform well in the last session? - US Post News

Oct 03, 2024

Oct 03, 2024

Adicet Bio, Inc.'s (NASDAQ:ACET) large institutional owners must be happy as stock continues to impress, up 11% over the past week - Simply Wall St

Oct 03, 2024

Oct 02, 2024

Recent Insider Activity Suggests Potential Gains for Adicet Bio Inc (ACET) - Knox Daily

Oct 02, 2024

Oct 01, 2024

Adicet Bio stock maintains neutral rating amid lupus nephritis trial - Investing.com

Oct 01, 2024

Oct 01, 2024

Stonepine Capital Management LLC Has $737,000 Holdings in Adicet Bio, Inc. (NASDAQ:ACET) - Defense World

Oct 01, 2024

Oct 01, 2024

Adicet Bio begins enrolling subjects in Phase I trial of autoimmune disease therapy - Clinical Trials Arena

Oct 01, 2024

Oct 01, 2024

Stonepine Capital Management LLC Increases Stake in Adicet Bio, Inc. (NASDAQ:ACET) - MarketBeat

Oct 01, 2024

Sep 30, 2024

Adicet Bio to Present at the American Society of Gene & Cell Therapy’s (ASGCT) 2024 Advancing Gene + Cell Therapies for Cancer Conference - Business Wire

Sep 30, 2024

Sep 30, 2024

Adicet Bio (NASDAQ:ACET) Stock Rating Reaffirmed by HC Wainwright - MarketBeat

Sep 30, 2024

Sep 30, 2024

Adicet Bio (NASDAQ:ACET) Now Covered by Analysts at Guggenheim - MarketBeat

Sep 30, 2024

Sep 30, 2024

Guggenheim Begins Coverage on Adicet Bio (NASDAQ:ACET) - Defense World

Sep 30, 2024

Sep 30, 2024

Adicet Opens Enrollment for ADI-001 Phase 1 Clinical Trial in Autoimmune Diseases - BioSpace

Sep 30, 2024

Sep 30, 2024

Adicet Bio Launches Phase 1 Trial of ADI-001, Eyes Expansion - TipRanks

Sep 30, 2024

Sep 27, 2024

Wall Street SWOT: Adicet Bio stock navigates competitive CAR-T waters - Investing.com

Sep 27, 2024

Sep 25, 2024

Biomarker Data from Oncology Trial for Adicet Bio’s Gamma Delta T-cell Therapy ADI-001 Indicates Potential for Use in Autoimmune Disease - CGTLive™

Sep 25, 2024